{"version":"1.0","type":"rich","provider_name":"Everlit","provider_url":"https://everlit.audio/","title":"Goldenrod Therapeutics raises $6.5 million to test UNMC-created drug that could change modern medicine","description":"Incubated by Houston-based Fannin Innovation Studio, the 11h drug created in Nebraska will move toward phase 1 clinical trials in humans. If successful, it could serve as a miracle treatment for…","author_name":"Silicon Prairie News","thumbnail_url":"https://cdn.everlit.audio/covers/artl_QWylHvoYlDa/eef85308-5656-4517-9b41-64b53694a84d/small.jpg","width":480,"height":136,"html":"\u003ciframe title=\"Goldenrod Therapeutics raises $6.5 million to test UNMC-created drug that could change modern medicine\" src=\"https://everlit.audio/embeds/artl_QWylHvoYlDa\" width=\"100%\" height=\"136px\" frameborder=\"0\" allow=\"accelerometer; autoplay; clipboard-write; encrypted-media; gyroscope; picture-in-picture; web-share\" allowfullscreen\u003e\u003c/iframe\u003e"}